Case Based Roundtable Logo

This roundtable series reviews the use of treatments targeting EGFR mutations in patients with locally advanced or metastatic non–small cell lung cancer, as discussed by participants at virtual live events.

First-Line Therapy With Bispecific Antibody for EGFR-Mutated NSCLC